Sector: Healthcare | Industry: Biotechnology & Medical Research |
Viventia Bio Inc is a Canada-based biological company. The Company is a biologics oncology company focused on designing, engineering and developing targeted protein therapeutics. The Company's advanced product candidates, Vicinium and Proxinium, are locally administered TPTs. The Company is engaged in developing next generation oncology therapeutics utilizing the Targeted Protein Therapeutic technology (TPT). The TPTs has been designed to overcome the efficacy and safety challenges of existing antibody-drug conjugates. The Company is engaged in designing, engineering, developing and commercializing TPTs to identify and address patients with cancers that has a high unmet medical needs.
See business summary